Osteoarthritis (OA) is the most common joint disease, generating pain, disability, and
socioeconomic costs worldwide. Currently there are no approved disease-modifying drugs …

Osteoarthritis (OA) is a degenerative joint disease, affecting 32.5 million US adults or 242
million people worldwide. There is no cure for OA. Many animal and clinical trials showed …

Introduction There is currently no disease-modifying drug for osteoarthritis (OA), and some
safety concerns have been identified about the leading traditional drugs. Therefore …

Simple Summary Osteoarthritis (OA), the most common joint disease affecting humans and
animals, is a painful, degenerative, and inflammatory disease that affects synovial joints and …

Objective: Prevalence of osteoarthritis (OA) is increasing alarmingly worldwide. Slowing
down the progression of OA and diverse locomotive organ disorders is gaining interest in …

Objective: To evaluate the effectiveness of treating osteoarthritis with the use of type II non-
denatured collagen (UCII). Methods: This is a study of systematic review and meta-analysis …

BACKGROUND: Available medication for pain and joint stiffness release in osteoarthritis
(OA) often gives considerable side effects. Undenatured type II collagen (UC-II) has been …

Osteoarthritis (OA) is the most common joint disease affecting millions worldwide.
Osteoarthritis typically affects the knees, hands, hips, and feet. It is characterized by complex …

Micronutrients play a key role in human health, being involved in energy metabolism,
immunity, cellular functioning, growth, and development. Deficiencies in micronutrients …

Аннотация В обзоре рассматривается весь спектр известных на сегодня
аутоантигенов при остеоартрите (ОА) и обсуждается их роль в возникновении и/или …